The House Energy and Commerce Committee today held a hearing on the administration’s response to the COVID-19 pandemic, which featured officials from the Department of Health and Human Services, National Institute of Allergy and Infectious Diseases, Food and Drug Administration, and Centers for Disease Control and Prevention.

NIAID Director Anthony Fauci, M.D., said the agency is supporting development of several SARS-CoV-2 vaccine candidates, including one by Moderna Inc. that could enter a phase 3 trial by July pending positive results in Phase 2. CDC Director Robert Redfield, M.D., also said the agency continues to work with states and communities to expand COVID-19 testing and contact tracing.

Related News Articles

Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…